Mitochondria and Tumorigenesis
DOI:
https://doi.org/10.62382/jcbt.v2i3.69Keywords:
Mitochondria, Oxidative phosphorylation (OXPHOS), Tricarboxylic acid (TCA), Warburg effect, Metabolic reprogrammingAbstract
Mitochondria are essential organelles in eukaryotes, serving as the cellular powerhouse for energy production. Mitochondrial dysregulation plays a pivotal role in disease progression by functioning as a "plasticity hub" that coordinates the dynamic tumor microenvironment. This coordination occurs via multidimensional mechanisms such as metabolic rewiring, bioenergetic flux disruption, stress-responsive signaling, and inter-organellar communication, collectively promoting cancer initiation, dissemination, and therapeutic evasion. The current review summarizes recent advances in understanding mitochondria-driven oncogenesis through these mechanisms, discusses mitochondrial-targeted therapeutic strategies and associated challenges, and aims to establish a cross-scale framework for decoding the multi-dimensional synergy of mitochondrial networks in cancer progression, thereby offering insights for developing innovative precision therapies that integrate metabolic-dynamic-immune interventions.
Downloads
References
Walker UA. Mitochondriale Medizin für Internisten [Mitochondrial medicine for internists]. Medizinische Klinik. 2000, 95(12), 689-96. DOI: 10.1007/pl00002087
Frey TG, Mannella CA. The internal structure of mitochondria. Trends Biochem Sci. 2000, 25(7), 319-24. DOI: 10.1016/s0968-0004(00)01609-1
Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell. 2012, 148(6), 1145-59. DOI: 10.1016/j.cell.2012.02.035
Harrington JS, Ryter SW, Plataki M, Price DR, Choi AMK. Mitochondria in health, disease, and aging. Physiological Reviews. 2023, 103(4), 2349-2422. DOI: 10.1152/physrev.00058.2021
Suomalainen A, Nunnari J. Mitochondria at the crossroads of health and disease. Cell. 2024, 187(11), 2601-2627. DOI: 10.1016/j.cell.2024.04.037
Kopinski PK, Singh LN, Zhang SP, Lott MT, Wallace DC. Mitochondrial DNA variation and cancer. Nature Reviews. Cancer. 2021, 21(7), 431-445. DOI: 10.1038/s41568-021-00358-w
Vadakedath S, Kandi V, Ca J, Vijayan S, Achyut KC, Uppuluri S, et al. Mitochondrial Deoxyribonucleic Acid (mtDNA), Maternal Inheritance, and Their Role in the Development of Cancers: A Scoping Review. Cureus. 2023, 15(6), e39812. DOI: 10.7759/cureus.39812
Kozakiewicz P, Grzybowska-Szatkowska L, Ciesielka M, Rzymowska J. The Role of Mitochondria in Carcinogenesis. International Journal of Molecular Sciences. 2021, 22(10), 5100. DOI: 10.3390/ijms22105100
Jafarinia M, Vos T, Lim SS, Naghavi M, Murray CJL, Onwujekwe O. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020, 396(10258), 1204-1222. DOI: 10.1016/S0140-6736(20)30925-9
Pegoraro C, Domingo-Ortí I, Conejos-Sánchez I, Vicent MJ. Unlocking the Mitochondria for Nanomedicine-based Treatments: Overcoming Biological Barriers, Improving Designs, and Selecting Verification Techniques. Advanced Drug Delivery Reviews. 2024, 207, 115195. DOI: 10.1016/j.addr.2024.115195
Choudhury FK. Mitochondrial Redox Metabolism: The Epicenter of Metabolism during Cancer Progression. Antioxidants (Basel). 2021, 10(11), 1838. DOI: 10.3390/antiox10111838
Ciccarone F, Ciriolo MR. Reprogrammed mitochondria: a central hub of cancer cell metabolism. Biochemical Society Transactions. 2024, 52(3), 1305-1315. DOI: 10.1042/BST20231090
Kukurugya MA, Rosset S, Titov DV. The Warburg Effect is the result of faster ATP production by glycolysis than respiration. Proceedings of the National Academy of Sciences of the United States of America. 2024, 121(46), e2409509121. DOI: 10.1073/pnas.2409509121
WARBURG O. On the origin of cancer cells. Science. 1956, 123(3191), 309-14. DOI: 10.1126/science.123.3191.309
Wang T, Sun FZ, Li CC, Nan P, Song Y, Wan XH, et al. MTA1, a Novel ATP Synthase Complex Modulator, Enhances Colon Cancer Liver Metastasis by Driving Mitochondrial Metabolism Reprogramming. Advanced Science. 2023, 10(25), e2300756. DOI: 10.1002/advs.202300756
Lai HW, Kasai M, Yamamoto S, Fukuhara H, Karashima T, Kurabayashi A, et al. Metabolic shift towards oxidative phosphorylation reduces cell-density-induced cancer-stem-cell-like characteristics in prostate cancer in vitro. Biology Open. 2023, 12(4), bio059615. DOI: 10.1242/bio.059615
Wu ZD, Zuo ML, Zeng L, Cui KS, Liu B, Yan CJ, et al. OMA1 reprograms metabolism under hypoxia to promote colorectal cancer development. EMBO Reports. 2021, 22(1), e50827. DOI: 10.15252/embr.202050827
Liu J, Peng YH, Shi L, Wan LX, Inuzuka H, Long JG, et al. Skp2 dictates cell cycle-dependent metabolic oscillation between glycolysis and TCA cycle. Cell Research. 2021, 31(1), 80-93. DOI: 10.1038/s41422-020-0372-z
Zeng SY, Hu X. Lactic acidosis switches cancer cells from dependence on glycolysis to OXPHOS and renders them highly sensitive to OXPHOS inhibitors. Biochemical and Biophysical Research Communications. 2023, 671, 46-57. DOI: 10.1016/j.bbrc.2023.05.097
Smith B, Schafer XL, Ambeskovic A, Spencer CM, Land H, Munger J. Addiction to Coupling of the Warburg Effect with Glutamine Catabolism in Cancer Cells. Cell Reports. 2016, 17(3), 821-836. DOI: 10.1016/j.celrep.2016.09.045
Son J, Lyssiotis CA, Ying HQ, Wang XX, Hua SJ, Ligorio M, et al. Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature. 2013, 496(7443), 101-5. DOI: 10.1038/nature12040
Mailloux RJ, Bériault R, Lemire J, Singh R, Chénier DR, Hamel RD, et al. The tricarboxylic acid cycle, an ancient metabolic network with a novel twist. PLoS One. 2007, 2(8), e690. DOI: 10.1371/journal.pone.0000690
Boese AC, Kang S. Mitochondrial metabolism-mediated redox regulation in cancer progression. Redox Biology. 2021, 42, 101870. DOI: 10.1016/j.redox.2021.101870
Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009, 324(5930), 1029-33. DOI: 10.1126/science.1160809
Filipp FV, Scott DA, Ronai ZA, Osterman AL, Smith JW. Reverse TCA cycle flux through isocitrate dehydrogenases 1 and 2 is required for lipogenesis in hypoxic melanoma cells. Pigment Cell & Melanoma Research. 2012, 25(3), 375-83. DOI: 10.1111/j.1755-148X.2012.00989.x
Faubert B, Vincent EE, Griss T, Samborska B, Izreig S, Svensson RU, et al. Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1α. Proceedings of the National Academy of Sciences of the United States of America. 2014, 111(7), 2554-9. DOI: 10.1073/pnas.1312570111
Guo D, Tong YY, Jiang XM, Meng Y, Jiang HF, Du LY, et al. Aerobic glycolysis promotes tumor immune evasion by hexokinase2-mediated phosphorylation of IκBα. Cell Metabolism. 2022, 34(9), 1312-1324.e6. DOI: 10.1016/j.cmet.2022.08.002
Fu Y, Zou TT, Shen XT, Nelson PJ, Li JH, Wu C, et al. Lipid metabolism in cancer progression and therapeutic strategies. MedComm (2020). 2020, 2(1), 27-59. DOI: 10.1002/mco2.27
Riscal R, Skuli N, Simon MC. Even Cancer Cells Watch Their Cholesterol! Molecular Cell. 2019, 76(2), 220-231. DOI: 10.1016/j.molcel.2019.09.008
Cheng CM, Geng F, Cheng X, Guo DL. Lipid metabolism reprogramming and its potential targets in cancer. Cancer Communications. 2018, 38(1), 27. DOI: 10.1186/s40880-018-0301-4
Baenke F, Peck B, Miess H, Schulze A. Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development. Disease Models & Mechanisms. 2013, 6(6), 1353-63. DOI: 10.1242/dmm.011338
Pellerin L, Carrié L, Dufau C, Nieto L, Ségui B, Levade T, et al. Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives. Cancers (Basel). 2020, 12(11), 3147. DOI: 10.3390/cancers12113147
Parrales A, Iwakuma T. p53 as a Regulator of Lipid Metabolism in Cancer. International Journal of Molecular Sciences. 2016, 17(12), 2074. DOI: 10.3390/ijms17122074
Yang K, Wang XK, Song CH, He Z, Wang RX, Xu YR, et al. The role of lipid metabolic reprogramming in tumor microenvironment. Theranostics. 2023, 13(6), 1774-1808. DOI: 10.7150/thno.82920
Tilokani L, Nagashima S, Paupe V, Prudent J. Mitochondrial dynamics: overview of molecular mechanisms. Essays Biochem. 2018, 62(3), 341-360. DOI: 10.1042/EBC20170104
Chen W, Zhao HK, Li YS. Mitochondrial dynamics in health and disease: mechanisms and potential targets. Signal Transduction and Targeted Therapy. 2023, 8(1), 333. DOI: 10.1038/s41392-023-01547-9
Liesa M, Palacín M, Zorzano A. Mitochondrial dynamics in mammalian health and disease. Physiological Reviews. 2009, 89(3), 799-845. DOI: 10.1152/physrev.00030.2008
Zhao J, Zhang J, Yu M, Xie Y, Huang Y, Wolff DW, et al. Mitochondrial dynamics regulates migration and invasion of breast cancer cells. Oncogene. 2013, 32(40), 4814-24. DOI: 10.1038/onc.2012.494
Han SY, Jeong YJ, Choi Y, Hwang SK, Bae YS, Chang YC. Mitochondrial dysfunction induces the invasive phenotype, and cell migration and invasion, through the induction of AKT and AMPK pathways in lung cancer cells. International Journal of Molecular Medicine. 2018, 42(3), 1644-1652. DOI:10.3892/ijmm.2018.3733
Kleele T, Rey T, Winter J, Zaganelli S, Mahecic D, Perreten Lambert H, et al. Distinct fission signatures predict mitochondrial degradation or biogenesis. Nature. 2021, 593(7859), 435-439. DOI: 10.1038/s41586-021-03510-6
Ma JT, Zhang XY, Cao R, Sun L, Jing W, Zhao JZ, et al. Effects of Dynamin-related Protein 1 Regulated Mitochondrial Dynamic Changes on Invasion and Metastasis of Lung Cancer Cells. Journal of Cancer. 2019, 10(17), 4045-4053. DOI: 10.7150/jca.29756
Yang YF, Ouyang YS, Yang LC, Beal MF, McQuibban A, Vogel H, et al. Pink1 regulates mitochondrial dynamics through interaction with the fission/fusion machinery. Proceedings of the National Academy of Sciences of the United States of America. 2008, 105(19), 7070-5. DOI: 10.1073/pnas.0711845105
Li YJ, Chen H, Yang Q, Wan LX, Zhao J, Wu YY, et al. Increased Drp1 promotes autophagy and ESCC progression by mtDNA stress mediated cGAS-STING pathway. Journal of Experimental & Clinical Cancer Research: CR. 2022, 41(1), 76. DOI: 10.1186/s13046-022-02262-z
Yin MJ, Lu Q, Liu X, Wang T, Liu Y, Chen LF. Silencing Drp1 inhibits glioma cells proliferation and invasion by RHOA/ ROCK1 pathway. Biochemical and Biophysical Research Communications. 2016, 478(2), 663-8. DOI: 10.1016/j.bbrc.2016.08.003
Humphries BA, Cutter AC, Buschhaus JM, Chen YC, Qyli T, Palagama DSW, et al. Enhanced mitochondrial fission suppresses signaling and metastasis in triple-negative breast cancer. Breast Cancer Research: BCR. 2020, 22(1), 60. DOI: 10.1186/s13058-020-01301-x
Sánchez-Alvarez R, De Francesco EM, Fiorillo M, Sotgia F, Lisanti MP. Mitochondrial Fission Factor (MFF) Inhibits Mitochondrial Metabolism and Reduces Breast Cancer Stem Cell (CSC) Activity. Frontiers in Oncology. 2020, 10, 1776. DOI: 10.3389/fonc.2020.01776
Parida PK, Marquez-Palencia M, Ghosh S, Khandelwal N, Kim K, Nair V, et al. Limiting mitochondrial plasticity by targeting DRP1 induces metabolic reprogramming and reduces breast cancer brain metastases. Nature Cancer. 2023, 893-907. DOI: 10.1038/s43018-023-00563-6
Wu D, Yang Y, Hou YR, Zhao ZF, Liang N, Yuan P, et al. Increased mitochondrial fission drives the reprogramming of fatty acid metabolism in hepatocellular carcinoma cells through suppression of Sirtuin 1. Cancer Communications. 2022, 42(1), 37-55. DOI: 10.1002/cac2.12247
Ippolito L, Morandi A, Taddei ML, Parri M, Comito G, Iscaro A, et al. Cancer-associated fibroblasts promote prostate cancer malignancy via metabolic rewiring and mitochondrial transfer. Oncogene. 2019, 38(27), 5339-5355. DOI:10.1038/s41388-019-0805-7
Gao S, Hu JJ. Mitochondrial Fusion: The Machineries In and Out. Trends in Cell Biology. 2021, 31(1), 62-74. DOI: 10.1016/j.tcb.2020.09.008
Meeusen SL, Nunnari J. How mitochondria fuse. Current Opinion in Cell Biology. 2005, 17(4), 389-94. DOI: 10.1016/j.ceb.2005.06.014
Griffin EE, Detmer SA, Chan DC. Molecular mechanism of mitochondrial membrane fusion. Biochimica et Biophysica Acta. 2006, 1763(5-6), 482-9. DOI: 10.1016/j.bbamcr.2006.02.003
Mishra P, Carelli V, Manfredi G, Chan DC. Proteolytic cleavage of Opa1 stimulates mitochondrial inner membrane fusion and couples fusion to oxidative phosphorylation. Cell Metabolism. 2014, 19(4), 630-41. DOI: 10.1016/j.cmet.2014.03.011
Archer SL. Mitochondrial dynamics--mitochondrial fission and fusion in human diseases. The New England Journal of Medicine. 2013, 369(23), 2236-51. DOI: 10.1056/NEJMra1215233
Wu ZH, Xiao C, Li F, Huang WB, You FM, Li XK. Mitochondrial fusion-fission dynamics and its involvement in colorectal cancer. Molecular Oncology. 2024, 18(5), 1058-1075. DOI: 10.1002/1878-0261.13578
Wu ZH, Xiao C, Long J, Huang WB, You FM, Li XK. Mitochondrial dynamics and colorectal cancer biology: mechanisms and potential targets. Cell Communication and Signaling: CCS. 2024, 22(1), 91. DOI: 10.1186/s12964-024-01490-4
Yu MF, Nguyen ND, Huang YQ, Lin D, Fujimoto TN, Molkentine JM, et al. Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. JCI Insight. 2019, 5(16), e126915. DOI: 10.1172/jci.insight.126915
Zamberlan M, Boeckx A, Muller F, Vinelli F, Ek O, Vianello C, et al. Inhibition of the mitochondrial protein Opa1 curtails breast cancer growth. Journal of Experimental & Clinical Cancer Research: CR. 2022, 41(1), 95. DOI: 10.1186/s13046-022-02304-6
Hill S, Van Remmen H. Mitochondrial stress signaling in longevity: a new role for mitochondrial function in aging. Redox Biology. 2014, 2, 936-44. DOI: 10.1016/j.redox.2014.07.005
Raimundo N. Mitochondrial pathology: stress signals from the energy factory. Trends in Molecular Medicine. 2014, 20(5), 282-92. DOI: 10.1016/j.molmed.2014.01.005
Ralph SJ, Rodríguez-Enríquez S, Neuzil J, Saavedra E, Moreno-Sánchez R. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy. Molecular Aspects of Medicine. 2010, 31(2), 145-70. DOI: 10.1016/j.mam.2010.02.008.
Balliet RM, Capparelli C, Guido C, Pestell TG, Martinez-Outschoorn UE, Lin Z, et al. Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth: understanding the aging and cancer connection. Cell Cycle. 2011, 10(23), 4065-73. DOI: 10.4161/cc.10.23.18254
Jin P, Jiang JW, Zhou L, Huang Z, Nice EC, Huang CH, et al. Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management. Journal of Hematology & Oncology. 2022, 15(1), 97. DOI: 10.1186/s13045-022-01313-4
Sabharwal SS, Schumacker PT. Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel? Nature Reviews. Cancer. 2014, 14(11), 709-21. DOI: 10.1038/nrc3803
Pelicano H, Carney D, Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resistance Updates: Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 2004, 7(2), 97-110. DOI: 10.1016/j.drup.2004.01.004
Wang YW, Qi H, Liu Y, Duan C, Liu XL, Xia T, et al. The double-edged roles of ROS in cancer prevention and therapy. Theranostics. 2021, 11(10), 4839-4857. DOI: 10.7150/thno.56747
Sharma V, Collins LB, Chen TH, Herr N, Takeda S, Sun W, et al. Oxidative stress at low levels can induce clustered DNA lesions leading to NHEJ mediated mutations. Oncotarget. 2016, 7(18), 25377-90. DOI: 10.18632/oncotarget.8298
Pan JS, Hong MZ, Ren JL. Reactive oxygen species: a double-edged sword in oncogenesis. World Journal of Gastroenterology. 2009, 15(14), 1702-7. DOI: 10.3748/wjg.15.1702
Kim BY, Han MJ, Chung AS. Effects of reactive oxygen species on proliferation of Chinese hamster lung fibroblast (V79) cells. Free Radical Biology & Medicine. 2001, 30(6), 686-98. DOI: 10.1016/s0891-5849(00)00514-1
Meloche S, Pouysségur J. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene. 2007, 26(22), 3227-39. DOI: 10.1038/sj.onc.1210414
Liu SL, Lin X, Shi DY, Cheng J, Wu CQ, Zhang YD. Reactive oxygen species stimulated human hepatoma cell proliferation via cross-talk between PI3-K/PKB and JNK signaling pathways. Archives of Biochemistry and Biophysics. 2002, 406(2), 173-82. DOI: 10.1016/s0003-9861(02)00430-7
Fantozzi A, Gruber DC, Pisarsky L, Heck C, Kunita A, Yilmaz M, et al. VEGF-mediated angiogenesis links EMT-induced cancer stemness to tumor initiation. Cancer Research. 2014, 74(5), 1566-75. DOI: 10.1158/0008-5472.CAN-13-1641
Xia C, Meng Q, Liu LZ, Rojanasakul Y, Wang XR, Jiang BH. Reactive oxygen species regulate angiogenesis and tumor growth through vascular endothelial growth factor. Cancer Research. 2007, 67(22), 10823-30. DOI: 10.1158/0008-5472.CAN-07-0783
Liu LZ, Hu XW, Xia C, He J, Zhou Q, Shi XL, et al. Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Radical Biology & Medicine. 2006, 41(10), 1521-33. DOI: 10.1016/j.freeradbiomed.2006.08.003
Ushio-Fukai M. Redox signaling in angiogenesis: role of NADPH oxidase. Cardiovascular Research. 2006, 71(2), 226-35. DOI: 10.1016/j.cardiores.2006.04.015
Dandapat A, Hu C, Sun L, Mehta JL. Small concentrations of oxLDL induce capillary tube formation from endothelial cells via LOX-1-dependent redox-sensitive pathway. Arteriosclerosis, Thrombosis, and Vascular Biology. 2007, 27(11), 2435-42. DOI: 10.1161/ATVBAHA.107.152272
Lee SY, Jeong EK, Ju MK, Jeon HM, Kim MY, Kim CH, et al. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation. Molecular Cancer. 2017, 16(1), 10. DOI: 10.1186/s12943-016-0577-4
Huang R, Chen H, Liang JY, Li Y, Yang JL, Luo C, et al. Dual Role of Reactive Oxygen Species and their Application in Cancer Therapy. Journal of Cancer. 2021, 12(18), 5543-5561. DOI: 10.7150/jca.54699
Kennel KB, Greten FR. Immune cell - produced ROS and their impact on tumor growth and metastasis. Redox Biology. 2021, 42, 101891. DOI: 10.1016/j.redox.2021.101891
Shah R, Ibis B, Kashyap M, Boussiotis VA. The role of ROS in tumor infiltrating immune cells and cancer immunotherapy. Metabolism: Clinical and Experimental. 2024, 151, 155747. DOI: 10.1016/j.metabol.2023.155747. Epub 2023 Nov 30
Xiang HD, Ramil CP, Hai J, Zhang CS, Wang HJ, Watkins AA, et al. Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell Carcinoma. Cancer Immunology Research. 2020, 8(4), 436-450. DOI: 10.1158/2326-6066.CIR-19-0507
Shimura T, Sasatani M, Kawai H, Kamiya K, Kobayashi J, Komatsu K, Kunugita N. Radiation-Induced Myofibroblasts Promote Tumor Growth via Mitochondrial ROS-Activated TGFβ Signaling. Molecular Cancer Research: MCR. 2018, 16(11), 1676-1686. DOI: 10.1158/1541-7786.MCR-18-0321
Kurata S. Selective activation of p38 MAPK cascade and mitotic arrest caused by low level oxidative stress. The Journal of Biological Chemistry. 2000, 275(31), 23413-6. DOI: 10.1074/jbc.C000308200
Lee SO, Joo SH, Kwak AW, Lee MH, Seo JH, Cho SS, et al. Podophyllotoxin Induces ROS-Mediated Apoptosis and Cell Cycle Arrest in Human Colorectal Cancer Cells via p38 MAPK Signaling. Biomolecules & Therapeutics. 2021, 29(6), 658-666. DOI: 10.4062/biomolther.2021.143
Kwak AW, Lee MJ, Lee MH, Yoon G, Cho SS, Chae JI, et al. The 3-deoxysappanchalcone induces ROS-mediated apoptosis and cell cycle arrest via JNK/p38 MAPKs signaling pathway in human esophageal cancer cells. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology. 2021, 86, 153564. DOI: 10.1016/j.phymed.2021.153564
Orrenius S, Gogvadze V, Zhivotovsky B. Mitochondrial oxidative stress: implications for cell death. Annual Review of Pharmacology and Toxicology. 2007, 47, 143-83. DOI: 10.1146/annurev.pharmtox.47.120505.105122
Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA, et al. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nature Chemical Biology. 2005, 1(4), 223-32. DOI: 10.1038/nchembio727
Wu HY, Huang CH, Lin YH, Wang CC, Jan TR. Cannabidiol induced apoptosis in human monocytes through mitochondrial permeability transition pore-mediated ROS production. Free Radical Biology & Medicine. 2018, 124, 311-318. DOI: 10.1016/j.freeradbiomed.2018.06.023
Madesh M, Hajnóczky G. VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release. The Journal of Cell Biology. 2001, 155(6), 1003-15. DOI: 10.1083/jcb.200105057
Chen ZX, Pervaiz S. Bcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells. Cell Death and Differentiation. 2007, 14(9), 1617-27. DOI: 10.1038/sj.cdd.4402165
Chen ZX, Pervaiz S. Involvement of cytochrome c oxidase subunits Va and Vb in the regulation of cancer cell metabolism by Bcl-2. Cell Death and Differentiation. 2010, 17(3), 408-20. DOI: 10.1038/cdd.2009.132
Kang YH, Lee SJ. The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells. Journal of Cellular Physiology. 2008, 217(1), 23-33. DOI: 10.1002/jcp.21470
Tsang WP, Chau SP, Kong SK, Fung KP, Kwok TT. Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis. Life Sciences. 2003, 73(16), 2047-58. DOI: 10.1016/s0024-3205(03)00566-6
Ma YF, Zhang J, Zhang Q, Chen P, Song JY, Yu SJ, et al. Adenosine induces apoptosis in human liver cancer cells through ROS production and mitochondrial dysfunction. Biochemical and Biophysical Research Communications. 2014, 448(1), 8-14. DOI: 10.1016/j.bbrc.2014.04.007
Liu Y, Borchert GL, Surazynski A, Hu CA, Phang JM. Proline oxidase activates both intrinsic and extrinsic pathways for apoptosis: the role of ROS/superoxides, NFAT and MEK/ERK signaling. Oncogene. 2006, 25(41), 5640-7. DOI: 10.1038/sj.onc.1209564
Chaudhary P, Vishwanatha JK. c-Jun NH2-terminal kinase-induced proteasomal degradation of c-FLIPL/S and Bcl2 sensitize prostate cancer cells to Fas- and mitochondria-mediated apoptosis by tetrandrine. Biochemical Pharmacology. 2014, 91(4), 457-73. DOI: 10.1016/j.bcp.2014.08.014
Gogna R, Madan E, Keppler B, Pati U. Gallium compound GaQ(3) -induced Ca(2+) signalling triggers p53-dependent and -independent apoptosis in cancer cells. British Journal of Pharmacology. 2012, 166(2), 617-36. DOI: 10.1111/j.1476-5381.2011.01780.x
Fujii S, Ushioda R, Nagata K. Redox states in the endoplasmic reticulum directly regulate the activity of calcium channel, inositol 1,4,5-trisphosphate receptors. Proceedings of the National Academy of Sciences of the United States of America. 2023, 120(22), e2216857120. DOI: 10.1073/pnas.2216857120
Hamilton S, Terentyeva R, Martin B, Perger F, Li J, Stepanov A, et al. Increased RyR2 activity is exacerbated by calcium leak-induced mitochondrial ROS. Basic Research in Cardiology. 2020, 115(4), 38. DOI: 10.1007/s00395-020-0797-z
Zeng YQ, Du QD, Zhang ZW, Ma J, Han L, Wang YY, et al. Curcumin promotes cancer-associated fibroblasts apoptosis via ROS-mediated endoplasmic reticulum stress. Archives of Biochemistry and Biophysics. 2020, 694, 108613. DOI: 10.1016/j.abb.2020.108613
Lin YN, Jiang M, Chen WJ, Zhao TJ, Wei YF. Cancer and ER stress: Mutual crosstalk between autophagy, oxidative stress and inflammatory response. Biomed Pharmacother. 2019, 118, 109249. DOI: 10.1016/j.biopha.2019.109249
Li LW, Xing ZH, Wang JY, Guo YH, Wu XM, Ma YM, et al. Hyaluronic acid-mediated targeted nano-modulators for activation of pyroptosis for cancer therapy through multichannel regulation of Ca2+ overload. International Journal of Biological Macromolecules. 2025, 299, 140116. DOI: 10.1016/j.ijbiomac.2025.140116
Yang XH, Jiang JT, Yang XY, Han JC, Zheng QS. Licochalcone A induces T24 bladder cancer cell apoptosis by increasing intracellular calcium levels. Molecular Medicine Reports. 2016, 14(1), 911-919. DOI: 10.3892/mmr.2016.5334
Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature. 2000, 403(6765), 98-103. DOI: 10.1038/47513
Yang J, Zhao XY, Tang M, Li L, Lei Y, Cheng P, et al. The role of ROS and subsequent DNA-damage response in PUMA-induced apoptosis of ovarian cancer cells. Oncotarget. 2017, 8(14), 23492-23506. DOI: 10.18632/oncotarget.15626
Zhou ZX, Fan YM, Zong RK, Tan K. The mitochondrial unfolded protein response: A multitasking giant in the fight against human diseases. Ageing Research Reviews. 2022, 81, 101702. DOI: 10.1016/j.arr.2022.101702
Zhu L, Zhou QL, He L, Chen LX. Mitochondrial unfolded protein response: An emerging pathway in human diseases. Free Radical Biology & Medicine. 2021, 163, 125-134. DOI: 10.1016/j.freeradbiomed.2020.12.013
Torres AK, Fleischhart V, Inestrosa NC. Mitochondrial unfolded protein response (UPRmt): what we know thus far. Frontiers in Cell and Developmental Biology. 2024, 12, 1405393. DOI: 10.3389/fcell.2024.1405393
Naresh NU, Haynes CM. Signaling and Regulation of the Mitochondrial Unfolded Protein Response. Cold Spring Harbor Perspectives in Biology. 2019, 11(6), a033944. DOI: 10.1101/cshperspect.a033944
Inigo JR, Chandra D. The mitochondrial unfolded protein response (UPRmt): shielding against toxicity to mitochondria in cancer. Journal of Hematology & Oncology. 2022, 15(1), 98. DOI: 10.1186/s13045-022-01317-0
Zhang XY, Fan YM, Tan K. A bird's eye view of mitochondrial unfolded protein response in cancer: mechanisms, progression and further applications. Cell Death & Disease. 2024, 15(9), 667. DOI: 10.1038/s41419-024-07049-y
Kenny TC, Craig AJ, Villanueva A, Germain D. Mitohormesis Primes Tumor Invasion and Metastasis. Cell Reports. 2019, 27(8), 2292-2303.e6. DOI: 10.1016/j.celrep.2019.04.095
An H, Zhou B, Hayakawa K, Durán Laforet V, Park JH, Nakamura Y, et al. ATF5-Mediated Mitochondrial Unfolded Protein Response (UPRmt) Protects Neurons Against Oxygen-Glucose Deprivation and Cerebral Ischemia. Stroke. 2024, 55(7), 1904-1913. DOI: 10.1161/STROKEAHA.123.045550
Sutandy FXR, Gößner I, Tascher G, Münch C. A cytosolic surveillance mechanism activates the mitochondrial UPR. Nature. 2023, 618(7966), 849-854. DOI: 10.1038/s41586-023-06142-0
Kumar R, Chaudhary AK, Woytash J, Inigo JR, Gokhale AA, Bshara W, et al. A mitochondrial unfolded protein response inhibitor suppresses prostate cancer growth in mice via HSP60. The Journal of Clinical Investigation. 2022, 132(13), e149906. DOI: 10.1172/JCI149906
Kenny TC, Gomez ML, Germain D. Mitohormesis, UPRmt, and the Complexity of Mitochondrial DNA Landscapes in Cancer. Cancer Research. 2019, 79(24), 6057-6066. DOI: 10.1158/0008-5472.CAN-19-1395
Schmidt O, Pfanner N, Meisinger C. Mitochondrial protein import: from proteomics to functional mechanisms. Nature reviews. Molecular Cell Biology. 2010, 11(9), 655-657. DOI: 10.1038/nrm2959
Cannino G, Di Liegro CM, Rinaldi AM. Nuclear-mitochondrial interaction. Mitochondrion. 2007, 7(6), 359-366. DOI: 10.1016/j.mito.2007.07.001
Quirós PM, Mottis A, Auwerx J. Mitonuclear communication in homeostasis and stress. Nature Reviews. Molecular Cell Biology. 2016, 17(4), 213-226. DOI: 10.1038/nrm.2016.23
Mottis A, Herzig S, Auwerx J. Mitocellular communication: Shaping health and disease. Science. 2019, 366(6467), 827-832. DOI: 10.1126/science.aax3768
Ng S, De Clercq I, Van Aken O, Law SR, Ivanova A, Willems P, et al. Anterograde and retrograde regulation of nuclear genes encoding mitochondrial proteins during growth, development, and stress. Molecular Plant. 2014, 7(7), 1075-1093. DOI: 10.1093/mp/ssu037
Popov LD. Mitochondria as intracellular signalling organelles. An update. Cellular Signalling. 2023, 109, 110794. DOI: 10.1016/j.cellsig.2023.110794
Rinaldi L, Delle Donne R, Borzacchiello D, Insabato L, Feliciello A. The role of compartmentalized signaling pathways in the control of mitochondrial activities in cancer cells. Biochimica et Biophysica Acta. Reviews on Cancer. 2018, 1869(2), 293-302. DOI: 10.1016/j.bbcan.2018.04.004
Shteinfer-Kuzmine A, Verma A, Arif T, Aizenberg O, Paul A, Shoshan-Barmaz V. Mitochondria and nucleus cross-talk: Signaling in metabolism, apoptosis, and differentiation, and function in cancer. IUBMB Life. 2021, 73(3), 492-510. DOI: 10.1002/iub.2407
Butow RA, Avadhani NG. Mitochondrial signaling: the retrograde response. Molecular Cell. 2004, 14(1), 1-15. DOI: 10.1016/s1097-2765(04)00179-0
Guha M, Avadhani NG. Mitochondrial retrograde signaling at the crossroads of tumor bioenergetics, genetics and epigenetics. Mitochondrion. 2013, 13(6), 577-591. DOI: 10.1016/j.mito.2013.08.007
Brini M. Ca(2+) signalling in mitochondria: mechanism and role in physiology and pathology. Cell Calcium. 2003, 34(4-5), 399-405. DOI: 10.1016/s0143-4160(03)00145-3
Park HK, Lee JE, Lim J, Kang BH. Mitochondrial Hsp90s suppress calcium-mediated stress signals propagating from mitochondria to the ER in cancer cells. Molecular Cancer. 2014, 13, 148. DOI: 10.1186/1476-4598-13-148
Amuthan G, Biswas G, Ananadatheerthavarada HK, Vijayasarathy C, Shephard HM, Avadhani NG. Mitochondrial stress-induced calcium signaling, phenotypic changes and invasive behavior in human lung carcinoma A549 cells. Oncogene. 2002, 21(51), 7839-7849. DOI: 10.1038/sj.onc.1205983
Lee YK, Yi EY, Park SY, Jang WJ, Han YS, Jegal ME, et al. Mitochondrial dysfunction suppresses p53 expression via calcium-mediated nuclear factor-kB signaling in HCT116 human colorectal carcinoma cells. BMB Reports. 2018, 51(6), 296-301. DOI: 10.5483/bmbrep.2018.51.6.232
Rodríguez-Hernández MA, de la Cruz-Ojeda P, López-Grueso MJ, Navarro-Villarán E, Requejo-Aguilar R, Castejón-Vega B, et al. Integrated molecular signaling involving mitochondrial dysfunction and alteration of cell metabolism induced by tyrosine kinase inhibitors in cancer. Redox Biology. 2020, 36, 101510. DOI: 10.1016/j.redox.2020.101510
Cardamone MD, Tanasa B, Cederquist CT, Huang J, Mahdaviani K, Li W, et al. Mitochondrial Retrograde Signaling in Mammals Is Mediated by the Transcriptional Cofactor GPS2 via Direct Mitochondria-to-Nucleus Translocation. Molecular Cell. 2018, 69(5), 757-772.e7. DOI: 10.1016/j.molcel.2018.01.037
Nargund AM, Pellegrino MW, Fiorese CJ, Baker BM, Haynes CM. Mitochondrial import efficiency of ATFS-1 regulates mitochondrial UPR activation. Science. 2012, 337(6094), 587-590. DOI: 10.1126/science.1223560
Heilig R, Lee J, Tait SWG. Mitochondrial DNA in cell death and inflammation. Biochemical Society Transactions. 2023, 51(1), 457-472. DOI: 10.1042/BST20221525
Xia LT, Yan XL, Zhang H. Mitochondrial DNA-activated cGAS-STING pathway in cancer: Mechanisms and therapeutic implications. Biochimica et Biophysica Acta. Reviews on Cancer. 2025, 1880(1), 189249. DOI: 10.1016/j.bbcan.2024.189249
Wang SF, Tseng LM, Lee HC. Role of mitochondrial alterations in human cancer progression and cancer immunity. Journal of Biomedical Science. 202, 30(1), 61. DOI: 10.1186/s12929-023-00956-w
Newman LE, Shadel GS. Mitochondrial DNA Release in Innate Immune Signaling. Annual Review of Biochemistry. 2023, 92, 299-332. DOI: 10.1146/annurev-biochem-032620-104401
Singh RK, Srivastava A, Kalaiarasan P, Manvati S, Chopra R, Bamezai RN. mtDNA germ line variation mediated ROS generates retrograde signaling and induces pro-cancerous metabolic features. Scientific Reports. 2014, 4, 6571. DOI: 10.1038/srep06571
Koenig A, Buskiewicz-Koenig IA. Redox Activation of Mitochondrial DAMPs and the Metabolic Consequences for Development of Autoimmunity. Antioxidants & Redox Signaling. 2022, 36(7-9), 441-461. DOI: 10.1089/ars.2021.0073
Li WT, Li YT, Zhao J, Liao JB, Wen WB, Chen Y, et al. Release of damaged mitochondrial DNA: A novel factor in stimulating inflammatory response. Pathology, Research and Practice. 2024, 258, 155330. DOI: 10.1016/j.prp.2024.155330
Ikeda H, Kawase K, Nishi T, Watanabe T, Takenaga K, Inozume T, et al. Immune evasion through mitochondrial transfer in the tumour microenvironment. Nature. 2025, 639(8053), E5. DOI: 10.1038/s41586-024-08439-0
Zhou Z, Qu CH, Zhou PJ, Zhou Q, Li D, Wu X, et al. Extracellular vesicles activated cancer-associated fibroblasts promote lung cancer metastasis through mitophagy and mtDNA transfer. Journal of Experimental & Clinical Cancer Research: CR. 2024, 43(1), 158. DOI: 10.1186/s13046-024-03077-w
Patrushev M, Kasymov V, Patrusheva V, Ushakova T, Gogvadze V, Gaziev A. Mitochondrial permeability transition triggers the release of mtDNA fragments. Cellular and Molecular Life Sciences: CMLS. 2004, 61(24), 3100-3103. DOI: 10.1007/s00018-004-4424-1
Zecchini V, Paupe V, Herranz-Montoya I, Janssen J, Wortel IMN, Morris JL, et al. Fumarate induces vesicular release of mtDNA to drive innate immunity. Nature. 2023, 615(7952), 499-506. DOI: 10.1038/s41586-023-05770-w
Jibril A, Hellmich C, Wojtowicz EE, Hampton K, Maynard R, De Silva R, et al. Plasma cell-derived mtDAMPs activate the macrophage STING pathway, promoting myeloma progression. Blood. 2023, 141(25), 3065-3077. DOI: 10.1182/blood.2022018711
Guha M, Srinivasan S, Ruthel G, Kashina AK, Carstens RP, Mendoza A, et al. Mitochondrial retrograde signaling induces epithelial-mesenchymal transition and generates breast cancer stem cells. Oncogene. 2014, 33(45), 5238-5250. DOI: 10.1038/onc.2013.467
Liu S, Feng M, Guan WX. Mitochondrial DNA sensing by STING signaling participates in inflammation, cancer and beyond. International Journal of Cancer. 2016, 139(4), 736-741. DOI: 10.1002/ijc.30074
Liu Y, Chen C, Wang XY, Sun YH, Zhang J, Chen JX, et al. An Epigenetic Role of Mitochondria in Cancer. Cells. 2022, 11(16), 2518. DOI: 10.3390/cells11162518
Santos JH. Mitochondria signaling to the epigenome: A novel role for an old organelle. Free Radical Biology & Medicine. 2021, 170, 59-69. DOI: 10.1016/j.freeradbiomed.2020.11.016
Campbell SL, Wellen KE. Metabolic Signaling to the Nucleus in Cancer. Molecular Cell. 2018, 71(3), 398-408. DOI: 10.1016/j.molcel.2018.07.015
Corbet C, Pinto A, Martherus R, Santiago de Jesus JP, Polet F, Feron O. Acidosis Drives the Reprogramming of Fatty Acid Metabolism in Cancer Cells through Changes in Mitochondrial and Histone Acetylation. Cell Metabolism. 2016, 24(2), 311-323. DOI: 10.1016/j.cmet.2016.07.003
Ohshima K, Oi R, Nojima S, Morii E. Mitochondria govern histone acetylation in colorectal cancer. The Journal of Pathology. 2022, 256(2), 164-173. DOI: 10.1002/path.5818
Lee JV, Carrer A, Shah S, Snyder NW, Wei S, Venneti S, et al. Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. Cell Metabolism. 2014, 20(2), 306-319. DOI: 10.1016/j.cmet.2014.06.004
He WJ, Li QG, Li XX. Acetyl-CoA regulates lipid metabolism and histone acetylation modification in cancer. Biochimica et Biophysica Acta. Reviews on Cancer. 2023, 1878(1), 188837. DOI: 10.1016/j.bbcan.2022.188837
Han LM, Zhang CY, Wang DN, Zhang JQ, Tang QQ, Li MJ, et al. Retrograde regulation of mitochondrial fission and epithelial to mesenchymal transition in hepatocellular carcinoma by GCN5L1. Oncogene. 2023, 42(13), 1024-1037. DOI: 10.1038/s41388-023-02621-w
Hu XW, Wang DD, Sun LY, Gao Y, Zhou DZ, Tong XM, et al. Disturbed mitochondrial acetylation in accordance with the availability of acetyl groups in hepatocellular carcinoma. Mitochondrion. 2021, 60, 150-159. DOI: 10.1016/j.mito.2021.08.004
Madiraju P, Pande SV, Prentki M, Madiraju SR. Mitochondrial acetylcarnitine provides acetyl groups for nuclear histone acetylation. Epigenetics. 2009, 4(6), 399-403. DOI: 10.4161/epi.4.6.9767
Giangregorio N, Tonazzi A, Console L, Indiveri C. Post-translational modification by acetylation regulates the mitochondrial carnitine/acylcarnitine transport protein. Molecular and Cellular Biochemistry. 2017, 426(1-2), 65-73. DOI: 10.1007/s11010-016-2881-0
Takahashi H, McCaffery JM, Irizarry RA, Boeke JD. Nucleocytosolic acetyl-coenzyme a synthetase is required for histone acetylation and global transcription. Molecular Cell. 2006, 23(2), 207-217. DOI: 10.1016/j.molcel.2006.05.040
Chrun ES, Modolo F, Daniel FI. Histone modifications: A review about the presence of this epigenetic phenomenon in carcinogenesis. Pathology, Research and Practice. 2017, 213(11), 1329-1339. DOI: 10.1016/j.prp.2017.06.013
Fraga MF, Ballestar E, Villar-Garea A, Boix-Chornet M, Espada J, Schotta G, et al. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nature Genetics. 2005, 37(4), 391-400. DOI: 10.1038/ng1531
Neganova ME, Klochkov SG, Aleksandrova YR, Aliev G. Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress. Seminars in Cancer Biology. 2022, 83, 452-471. DOI: 10.1016/j.semcancer.2020.07.015
Zhao D, Li FL, Cheng ZL, Lei QY. Impact of acetylation on tumor metabolism. Molecular & Cellular Oncology. 2014, 1(3), e963452. DOI: 10.4161/23723548.2014.963452
Miziak P, Baran M, Borkiewicz L, Trombik T, Stepulak A. Acetylation of Histone H3 in Cancer Progression and Prognosis. International Journal of Molecular Sciences. 2024, 25(20), 10982. DOI: 10.3390/ijms252010982
Ono S, Oue N, Kuniyasu H, Suzuki T, Ito R, Matsusaki K, et al. Acetylated histone H4 is reduced in human gastric adenomas and carcinomas. Journal of Experimental & Clinical Cancer Research: CR. 2002, 21(3), 377-382. PMID: 12385581.
Kanao K, Mikami S, Mizuno R, Shinojima T, Murai M, Oya M. Decreased acetylation of histone H3 in renal cell carcinoma: a potential target of histone deacetylase inhibitors. The Journal of Urology. 2008, 180(3), 1131-6. DOI: 10.1016/j.juro.2008.04.136
Leggatt GR, Gabrielli B. Histone deacetylase inhibitors in the generation of the anti-tumour immune response. Immunology and Cell Biology. 2012, 90(1), 33-38. DOI: 10.1038/icb.2011.94
Yasui W, Oue N, Ono S, Mitani Y, Ito R, Nakayama H. Histone acetylation and gastrointestinal carcinogenesis. Annals of the New York Academy of Sciences. 2003, 983, 220-231. DOI: 10.1111/j.1749-6632.2003.tb05977.x
Mato JM, Alvarez L, Ortiz P, Pajares MA. S-adenosylmethionine synthesis: molecular mechanisms and clinical implications. Pharmacology & Therapeutics. 1997, 73(3), 265-280. DOI: 10.1016/s0163-7258(96)00197-0
Ouyang Y, Wu Q, Li JJ, Sun S, Sun SR. S-adenosylmethionine: A metabolite critical to the regulation of autophagy. Cell Proliferation. 2020, 53(11), e12891. DOI: 10.1111/cpr.12891
Rosenberger FA, Moore D, Atanassov I, Moedas MF, Clemente P, Végvári Á, et al. The one-carbon pool controls mitochondrial energy metabolism via complex I and iron-sulfur clusters. Science Advances. 2021, 7(8), eabf0717. DOI: 10.1126/sciadv.abf0717
Lozoya OA, Martinez-Reyes I, Wang TY, Grenet D, Bushel P, Li JY, et al. Mitochondrial nicotinamide adenine dinucleotide reduced (NADH) oxidation links the tricarboxylic acid (TCA) cycle with methionine metabolism and nuclear DNA methylation. PLoS Biology. 2018, 16(4), e2005707. DOI: 10.1371/journal.pbio.2005707
Luo J, Li YN, Wang F, Zhang WM, Geng X. S-adenosylmethionine inhibits the growth of cancer cells by reversing the hypomethylation status of c-myc and H-ras in human gastric cancer and colon cancer. International Journal of Biological Sciences. 2010, 6(7), 784-795. DOI: 10.7150/ijbs.6.784
Nohara K, Baba T, Murai H, Kobayashi Y, Suzuki T, Tateishi Y, et al. Global DNA methylation in the mouse liver is affected by methyl deficiency and arsenic in a sex-dependent manner. Archives of Toxicology. 2011, 85(6), 653-661. DOI: 10.1007/s00204-010-0611-z
Schmidt T, Leha A, Salinas-Riester G. Treatment of prostate cancer cells with S-adenosylmethionine leads to genome-wide alterations in transcription profiles. Gene. 2016, 595(2), 161-167. DOI: 10.1016/j.gene.2016.09.032
Haws SA, Yu DY, Ye CQ, Wille CK, Nguyen LC, Krautkramer KA, et al. Methyl-Metabolite Depletion Elicits Adaptive Responses to Support Heterochromatin Stability and Epigenetic Persistence. Molecular Cell. 2020, 78(2), 210-223.e8. DOI: 10.1016/j.molcel.2020.03.004
Frau M, Feo F, Pascale RM. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis. Journal of Hepatology. 2013, 59(4), 830-841. DOI: 10.1016/j.jhep.2013.04.031
Mentch SJ, Mehrmohamadi M, Huang L, Liu X, Gupta D, Mattocks D, et al. Histone Methylation Dynamics and Gene Regulation Occur through the Sensing of One-Carbon Metabolism. Cell Metabolism. 2015, 22(5), 861-873. DOI: 10.1016/j.cmet.2015.08.024
Shyh-Chang N, Locasale JW, Lyssiotis CA, Zheng YX, Teo RY, Ratanasirintrawoot S, et al. Influence of threonine metabolism on S-adenosylmethionine and histone methylation. Science. 2013, 339(6116), 222-226. DOI: 10.1126/science.1226603
Ye CQ, Sutter BM, Wang Y, Kuang Z, Tu BP. A Metabolic Function for Phospholipid and Histone Methylation. Molecular Cell. 2017, 66(2), 180-193.e8. DOI: 10.1016/j.molcel.2017.02.026
Mentch SJ, Locasale JW. One-carbon metabolism and epigenetics: understanding the specificity. Annals of the New York Academy of Sciences. 2016, 1363(1), 91-98. DOI: 10.1111/nyas.12956
Idaghdour Y, Hodgkinson A. Integrated genomic analysis of mitochondrial RNA processing in human cancers. Genome Medicine. 2017, 9(1), 36. DOI: 10.1186/s13073-017-0426-0
Salminen A, Kauppinen A, Hiltunen M, Kaarniranta K. Krebs cycle intermediates regulate DNA and histone methylation: epigenetic impact on the aging process. Ageing Research Reviews. 2014, 16, 45-65. DOI: 10.1016/j.arr.2014.05.004
Xiao MT, Yang H, Xu W, Ma SH, Lin HP, Zhu HG, et al. Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes & Development. 2012, 26(12), 1326-1338. DOI: 10.1101/gad.191056.112
Tsukada Y, Fang J, Erdjument-Bromage H, Warren ME, Borchers CH, Tempst P, et al. Histone demethylation by a family of JmjC domain-containing proteins. Nature. 2006, 439(7078), 811-816. DOI: 10.1038/nature04433
Soloveychik M, Xu MS, Zaslaver O, Lee K, Narula A, Jiang R, et al. Mitochondrial control through nutritionally regulated global histone H3 lysine-4 demethylation. Scientific Reports. 2016, 6, 37942. DOI: 10.1038/srep37942
Xiang Y, Zhu ZQ, Han G, Ye XL, Xu B, Peng ZC, et al. JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer. Proceedings of the National Academy of Sciences of the United States of America. 2007, 104(49), 19226-19231. DOI: 10.1073/pnas.0700735104
Young NL, Dere R. Mechanistic insights into KDM4A driven genomic instability. Biochemical Society Transactions. 2021, 49(1), 93-105. DOI: 10.1042/BST20191219
Salminen A, Kaarniranta K, Hiltunen M, Kauppinen A. Krebs cycle dysfunction shapes epigenetic landscape of chromatin: novel insights into mitochondrial regulation of aging process. Cellular Signalling. 2014, 26(7), 1598-603. DOI: 10.1016/j.cellsig.2014.03.030
Carey BW, Finley LW, Cross JR, Allis CD, Thompson CB. Intracellular α-ketoglutarate maintains the pluripotency of embryonic stem cells. Nature. 2015, 518(7539), 413-416. DOI: 10.1038/nature13981
Zhang D, Tang ZY, Huang H, Zhou GL, Cui C, Weng YJ, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019, 574(7779), 575-580. DOI: 10.1038/s41586-019-1678-1
Zhang Y, Song H, Li ML, Lu PR. Histone lactylation bridges metabolic reprogramming and epigenetic rewiring in driving carcinogenesis: Oncometabolite fuels oncogenic transcription. Clinical and Translational Medicine. 2024, 14(3), e1614. DOI: 10.1002/ctm2.1614
Yang ZJ, Zheng YQ, Gao Q. Lysine lactylation in the regulation of tumor biology. Trends in Endocrinology and Metabolism: TEM. 2024, 35(8), 720-731. DOI: 10.1016/j.tem.2024.01.011
Zhao P, Qiao CZ, Wang JW, Zhou Y, Zhang CH. Histone lactylation facilitates hepatocellular carcinoma progression by upregulating endothelial cell-specific molecule 1 expression. Molecular Carcinogenesis. 2024, 63(11), 2078-2089. DOI: 10.1002/mc.23794
Zhang C, Zhou LJ, Zhang MY, Du Y, Li C, Ren HJ, et al. H3K18 Lactylation Potentiates Immune Escape of Non-Small Cell Lung Cancer. Cancer Research. 2024, 84(21), 3589-3601. DOI: 10.1158/0008-5472.CAN-23-3513
Yang H, Zou XM, Yang SF, Zhang AG, Li NN, Ma Z. Identification of lactylation related model to predict prognostic, tumor infiltrating immunocytes and response of immunotherapy in gastric cancer. Frontiers in Immunology. 2023, 14, 1149989. DOI: 10.3389/fimmu.2023.1149989
Wang X, Liu XH, Xiao RL, Fang Y, Zhou FH, Gu MZ, et al. Histone lactylation dynamics: Unlocking the triad of metabolism, epigenetics, and immune regulation in metastatic cascade of pancreatic cancer. Cancer Letters. 2024, 598, 217117. DOI: 10.1016/j.canlet.2024.217117
Wang RJ, Li CW, Cheng ZY, Li MY, Shi JB, Zhang ZY, et al. H3K9 lactylation in malignant cells facilitates CD8+ T cell dysfunction and poor immunotherapy response. Cell Reports. 2024, 43(9), 114686. DOI: 10.1016/j.celrep.2024.114686
Anderson NM, Simon MC. The tumor microenvironment. Current Biology: CB. 2020, 30(16), R921-R925. DOI: 10.1016/j.cub.2020.06.081
Bharadwaj D, Mandal M. Tumor microenvironment: A playground for cells from multiple diverse origins. Biochimica et Biophysica Acta. Reviews on Cancer. 2024, 1879(5), 189158. DOI: 10.1016/j.bbcan.2024.189158
Ingravallo G, Tamma R, Opinto G, Annese T, Gaudio F, Specchia G, et al. The Effect of the Tumor Microenvironment on Lymphoid Neoplasms Derived from B Cells. Diagnostics (Basel). 2022, 12(3), 573. DOI: 10.3390/diagnostics12030573
Wang Q, Yin XZ, Huang XT, Zhang L, Lu HJ. Impact of mitochondrial dysfunction on the antitumor effects of immune cells. Frontiers in Immunology. 2024, 15, 1428596. DOI: 10.3389/fimmu.2024.1428596
Porporato PE, Filigheddu N, Pedro JMB, Kroemer G, Galluzzi L. Mitochondrial metabolism and cancer. Cell Research. 2018, 28(3), 265-280. DOI: 10.1038/cr.2017.155
Siska PJ, Singer K, Evert K, Renner K, Kreutz M. The immunological Warburg effect: Can a metabolic-tumor-stroma score (MeTS) guide cancer immunotherapy? Immunological Reviews. 2020, 295(1), 187-202. DOI: 10.1111/imr.12846
Jiang MQ, Wang YC, Zhao XY, Yu JM. From metabolic byproduct to immune modulator: the role of lactate in tumor immune escape. Frontiers in Immunology. 2024, 15, 1492050. DOI: 10.3389/fimmu.2024.1492050
Romero-Garcia S, Moreno-Altamirano MM, Prado-Garcia H, Sánchez-García FJ. Lactate Contribution to the Tumor Microenvironment: Mechanisms, Effects on Immune Cells and Therapeutic Relevance. Frontiers in Immunology. 2016, 7, 52. DOI: 10.3389/fimmu.2016.00052
Ramapriyan R, Caetano MS, Barsoumian HB, Mafra ACP, Zambalde EP, Menon H, et al. Altered cancer metabolism in mechanisms of immunotherapy resistance. Pharmacology & Therapeutics. 2019, 195, 162-171. DOI: 10.1016/j.pharmthera.2018.11.004
Lim S, Phillips JB, Madeira da Silva L, Zhou M, Fodstad O, Owen LB, et al. Interplay between Immune Checkpoint Proteins and Cellular Metabolism. Cancer Research. 2017, 77(6), 1245-1249. DOI: 10.1158/0008-5472.CAN-16-1647
Xia L, Oyang L, Lin J, Tan S, Han Y, Wu N, et al. The cancer metabolic reprogramming and immune response. Molecular Cancer. 2021, 20(1), 28. DOI: 10.1186/s12943-021-01316-8
Song KH, Kim JH, Lee YH, Bae HC, Lee HJ, Woo SR, et al. Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance. The Journal of Clinical Investigation. 2018, 128(9), 4098-4114. DOI: 10.1172/JCI96804
Ding XC, Wang LL, Zhang XD, Xu JL, Li PF, Liang H, et al. The relationship between expression of PD-L1 and HIF-1α in glioma cells under hypoxia. Journal of Hematology & Oncology. 2021, 14(1), 92. DOI: 10.1186/s13045-021-01102-5
Chen F, Xue Y, Zhang W, Zhou H, Zhou Z, Chen T, et al. The role of mitochondria in tumor metastasis and advances in mitochondria-targeted cancer therapy. Cancer Metastasis Reviews. 2024, 43(4), 1419-1443. DOI: 10.1007/s10555-024-10211-9
Brestoff JR, Singh KK, Aquilano K, Becker LB, Berridge MV, Boilard E, et al. Recommendations for mitochondria transfer and transplantation nomenclature and characterization. Nature Metabolism. 2025, 7(1), 53-67. DOI: 10.1038/s42255-024-01200-x
Herst PM, Grasso C, Berridge MV. Metabolic reprogramming of mitochondrial respiration in metastatic cancer. Cancer Metastasis Reviews. 2018, 37(4), 643-653. DOI: 10.1007/s10555-018-9769-2
Bjerring JS, Khodour Y, Peterson EA, Sachs PC, Bruno RD. Intercellular mitochondrial transfer contributes to microenvironmental redirection of cancer cell fate. The FEBS Journal. 2025. DOI: 10.1111/febs.70002
Kuo FC, Tsai HY, Cheng BL, Tsai KJ, Chen PC, Huang YB, et al. Endothelial Mitochondria Transfer to Melanoma Induces M2-Type Macrophage Polarization and Promotes Tumor Growth by the Nrf2/HO-1-Mediated Pathway. International Journal of Molecular Sciences. 2024, 25(3), 1857. DOI: 10.3390/ijms25031857
Watson DC, Bayik D, Storevik S, Moreino SS, Sprowls SA, Han J, et al. GAP43-dependent mitochondria transfer from astrocytes enhances glioblastoma tumorigenicity. Nature Cancer. 2023, 4(5), 648-664. DOI: 10.1038/s43018-023-00556-5
Moschoi R, Imbert V, Nebout M, Chiche J, Mary D, Prebet T, et al. Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy. Blood. 2016, 128(2), 253-64. DOI: 10.1182/blood-2015-07-655860
Sun C, Liu X, Wang B, Wang Z, Liu Y, Di C, et al. Endocytosis-mediated mitochondrial transplantation: Transferring normal human astrocytic mitochondria into glioma cells rescues aerobic respiration and enhances radiosensitivity. Theranostics. 2019, 9(12), 3595-3607. DOI: 10.7150/thno.33100
Ding P, Gao C, Zhou J, Mei J, Li G, Liu D, et al. Mitochondria from osteolineage cells regulate myeloid cell-mediated bone resorption. Nature Communications. 2024, 15(1), 5094. DOI: 10.1038/s41467-024-49159-3
Zhang H, Yu X, Ye J, Li H, Hu J, Tan Y, et al. Systematic investigation of mitochondrial transfer between cancer cells and T cells at single-cell resolution. Cancer Cell. 2023, 41(10), 1788-1802.e10. DOI: 10.1016/j.ccell.2023.09.003
Cai W, Zhang J, Yu Y, Ni Y, Wei Y, Cheng Y, et al. Mitochondrial Transfer Regulates Cell Fate Through Metabolic Remodeling in Osteoporosis. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 2023, 10(4), e2204871. DOI: 10.1002/advs.202204871
Baldwin JG, Heuser-Loy C, Saha T, Schelker RC, Slavkovic-Lukic D, Strieder N, et al. Intercellular nanotube-mediated mitochondrial transfer enhances T cell metabolic fitness and antitumor efficacy. Cell. 2024, 187(23), 6614-6630.e21. DOI: 10.1016/j.cell.2024.08.029
Headley CA, Gautam S, Olmo-Fontanez A, Garcia-Vilanova A, Dwivedi V, Akhter A, et al. Extracellular Delivery of Functional Mitochondria Rescues the Dysfunction of CD4+ T Cells in Aging. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 2024, 11(5), e2303664. DOI: 10.1002/advs.202303664
Kidwell CU, Casalini JR, Pradeep S, Scherer SD, Greiner D, Bayik D, et al. Transferred mitochondria accumulate reactive oxygen species, promoting proliferation. Elife. 2023, 12, e85494. DOI: 10.7554/eLife.85494
Sasaki R, Luo Y, Kishi S, Ogata R, Nishiguchi Y, Sasaki T, et al. Oxidative High Mobility Group Box-1 Accelerates Mitochondrial Transfer from Mesenchymal Stem Cells to Colorectal Cancer Cells Providing Cancer Cell Stemness. International Journal of Molecular Sciences. 2025, 26(3), 1192. DOI: 10.3390/ijms26031192
Chang JC, Chang HS, Wu YC, Cheng WL, Lin TT, Chang HJ, et al. Mitochondrial transplantation regulates antitumour activity, chemoresistance and mitochondrial dynamics in breast cancer. Journal of Experimental & Clinical Cancer Research: CR. 2019, 38(1), 30. DOI: 10.1186/s13046-019-1028-z
Marlein CR, Piddock RE, Mistry JJ, Zaitseva L, Hellmich C, Horton RH, et al. CD38-Driven Mitochondrial Trafficking Promotes Bioenergetic Plasticity in Multiple Myeloma. Cancer Research. 2019, 79(9), 2285-2297. DOI: 10.1158/0008-5472.CAN-18-0773
Goliwas KF, Libring S, Berestesky E, Gholizadeh S, Schwager SC, Frost AR, et al. Mitochondrial transfer from cancer-associated fibroblasts increases migration in aggressive breast cancer. Journal of Cell Science. 2023, 136(14), jcs260419. DOI: 10.1242/jcs.260419
He X, Zhong L, Wang N, Zhao B, Wang Y, Wu X, et al. Gastric Cancer Actively Remodels Mechanical Microenvironment to Promote Chemotherapy Resistance via MSCs-Mediated Mitochondrial Transfer. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 2024, 11(47), e2404994. DOI: 10.1002/advs.202404994
Qiao X, Huang N, Meng W, Liu Y, Li J, Li C, et al. Beyond mitochondrial transfer, cell fusion rescues metabolic dysfunction and boosts malignancy in adenoid cystic carcinoma. Cell Reports. 2024, 43(9), 114652. DOI: 10.1016/j.celrep.2024.114652
Alves AP, Mamede AC, Alves MG, Oliveira PF, Rocha SM, Botelho MF, et al. Glycolysis Inhibition as a Strategy for Hepatocellular Carcinoma Treatment? Current Cancer Drug Targets. 2019, 19(1), 26-40. DOI: 10.2174/1568009618666180430144441
Zheng M, Wu C, Yang K, Yang Y, Liu Y, Gao S, et al. Novel selective hexokinase 2 inhibitor Benitrobenrazide blocks cancer cells growth by targeting glycolysis. Pharmacological Research. 2021, 164, 105367. DOI: 10.1016/j.phrs.2020.105367
Zhao L, Kang M, Liu X, Wang Z, Wang Y, Chen H, et al. UBR7 inhibits HCC tumorigenesis by targeting Keap1/Nrf2/Bach1/HK2 and glycolysis. Journal of Experimental & Clinical Cancer Research: CR. 2022, 41(1), 330. DOI: 10.1186/s13046-022-02528-6
Sheng H, Tang W. Glycolysis Inhibitors for Anticancer Therapy: A Review of Recent Patents. Recent Patents on Anti-Cancer Drug Discovery. 2016, 11(3), 297-308. DOI: 10.2174/1574892811666160415160104
Shankar Babu M, Mahanta S, Lakhter AJ, Hato T, Paul S, Naidu SR. Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2. PLoS One. 2018, 13(2), e0191419. DOI: 10.1371/journal.pone.0191419
Yeung C, Gibson AE, Issaq SH, Oshima N, Baumgart JT, Edessa LD, et al. Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma. Cancer Research. 2019, 79(19), 5060-5073. DOI: 10.1158/0008-5472.CAN-19-0217
Zhang W, Zhang SL, Hu X, Tam KY. Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target? International Journal of Biological Sciences. 2015, 11(12), 1390-400. DOI: 10.7150/ijbs.13325
Bodmer M, Becker C, Meier C, Jick SS, Meier CR. Use of metformin and the risk of ovarian cancer: a case-control analysis. Gynecologic Oncology. 2011, 123(2), 200-4. DOI: 10.1016/j.ygyno.2011.06.038
Molina JR, Sun Y, Protopopova M, Gera S, Bandi M, Bristow C, et al. An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nature Medicine. 2018, 24(7), 1036-1046. DOI: 10.1038/s41591-018-0052-4
Ashton TM, McKenna WG, Kunz-Schughart LA, Higgins GS. Oxidative Phosphorylation as an Emerging Target in Cancer Therapy. Clinical Cancer Research. 2018, 24(11), 2482-2490. DOI: 10.1158/1078-0432.CCR-17-3070
Guardado Rivas MO, Stuart SD, Thach D, Dahan M, Shorr R, Zachar Z, et al. Evidence for a novel, effective approach to targeting carcinoma catabolism exploiting the first-in-class, anti-cancer mitochondrial drug, CPI-613. PLoS One. 2022, 17(6), e0269620. DOI: 10.1371/journal.pone.0269620
Winter M, Nait Eldjoudi A, Guette C, Hondermarck H, Bourette RP, Fovez Q, et al. Mitochondrial adaptation decreases drug sensitivity of persistent triple negative breast cancer cells surviving combinatory and sequential chemotherapy. Neoplasia. 2023, 46, 100949. DOI: 10.1016/j.neo.2023.100949
Casas-Benito A, Martínez-Herrero S, Martínez A. Succinate-Directed Approaches for Warburg Effect-Targeted Cancer Management, an Alternative to Current Treatments? Cancers (Basel). 2023, 15(10), 2862. DOI: 10.3390/cancers15102862
Chang Y, Du R, Xia F, Xu X, Wang H, Chen X. Dysregulation of Fatty Acid Metabolism in Breast Cancer and Its Targeted Therapy. Breast Cancer (Dove Med Press). 2024, 16, 825-844. DOI: 10.2147/BCTT.S496322
Komza M, Chipuk JE. Mitochondrial metabolism: A moving target in hepatocellular carcinoma therapy. Journal of Cellular Physiology. 2025, 240(1), e31441. DOI: 10.1002/jcp.31441
Jones SF, Infante JR. Molecular Pathways: Fatty Acid Synthase. Clinical Cancer Research. 2015, 21(24), 5434-8. DOI: 10.1158/1078-0432.CCR-15-0126
Marocchi F, Palluzzi F, Nicoli P, Melixetian M, Lovati G, Bertalot G, et al. Actionable Genetic Screens Unveil Targeting of AURKA, MEK, and Fatty Acid Metabolism as an Alternative Therapeutic Approach for Advanced Melanoma. The Journal of Investigative Dermatology. 2023, 143(10), 1993-2006.e10. DOI: 10.1016/j.jid.2023.03.1665
Iwamoto H, Abe M, Yang Y, Cui D, Seki T, Nakamura M, et al. Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance. Cell Metabolism. 2018, 28(1), 104-117.e5. DOI: 10.1016/j.cmet.2018.05.005
Amoedo ND, Sarlak S, Obre E, Esteves P, Bégueret H, Kieffer Y, et al. Targeting the mitochondrial trifunctional protein restrains tumor growth in oxidative lung carcinomas. The Journal of Clinical Investigation. 2021, 131(1), e133081. DOI: 10.1172/JCI133081
Ashley N, Poulton J. Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs. Biochemical and Biophysical Research Communications. 2009, 378(3), 450-5. DOI: 10.1016/j.bbrc.2008.11.059
Wisnovsky SP, Wilson JJ, Radford RJ, Pereira MP, Chan MR, Laposa RR, et al. Targeting mitochondrial DNA with a platinum-based anticancer agent. Chemistry & Biology. 2013, 20(11), 1323-8. DOI: 10.1016/j.chembiol.2013.08.010
de la Loza MC, Wellinger RE. A novel approach for organelle-specific DNA damage targeting reveals different susceptibility of mitochondrial DNA to the anticancer drugs camptothecin and topotecan. Nucleic Acids Research. 2009, 37(4), e26. DOI: 10.1093/nar/gkn1087
Somuncu B, Ekmekcioglu A, Antmen FM, Ertuzun T, Deniz E, Keskin N, et al. Targeting mitochondrial DNA polymerase gamma for selective inhibition of MLH1 deficient colon cancer growth. PLoS One. 2022, 17(6), e0268391. DOI: 10.1371/journal.pone.0268391
Battogtokh G, Choi YS, Kang DS, Park SJ, Shim MS, Huh KM, et al. Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives. Acta Pharmaceutica Sinica. B. 2018, 8(6), 862-880. DOI: 10.1016/j.apsb.2018.05.006
Lee JH, Kim KY, Jin H, Baek YE, Choi Y, Jung SH, et al. Self-Assembled Coumarin Nanoparticle in Aqueous Solution as Selective Mitochondrial-Targeting Drug Delivery System. ACS Applied Materials & Interfaces. 2018, 10(4), 3380-3391. DOI: 10.1021/acsami.7b17711
Ehsan S, Covarrubias-Zambrano O, Bossmann SH. Mitochondrial Targeting Peptide-based Nanodelivery for Cancer Treatment. Current Protein & Peptide Science. 2022, 23(10), 657-671. DOI: 10.2174/1389203723666220520160435
Wang Z, Guo W, Kuang X, Hou S, Liu H. Nanopreparations for mitochondria targeting drug delivery system: Current strategies and future prospective. Asian Journal of Pharmaceutical Sciences. 2017, 12(6), 498-508. DOI: 10.1016/j.ajps.2017.05.006
Sun Y, Yang Q, Xia X, Li X, Ruan W, Zheng M, et al. Polymeric Nanoparticles for Mitochondria Targeting Mediated Robust Cancer Therapy. Frontiers in Bioengineering and Biotechnology. 2021, 9, 755727. DOI: 10.3389/fbioe.2021.755727
Yamada Y, Munechika R, Satrialdi, Kubota F, Sato Y, Sakurai Y, et al. Mitochondrial Delivery of an Anticancer Drug Via Systemic Administration Using a Mitochondrial Delivery System That Inhibits the Growth of Drug-Resistant Cancer Engrafted on Mice. Journal of Pharmaceutical Sciences. 2020, 109(8), 2493-2500. DOI: 10.1016/j.xphs.2020.04.020
Shao X, Zhao X, Wang B, Fan J, Wang J, An H. Tumor microenvironment targeted nano-drug delivery systems for multidrug resistant tumor therapy. Theranostics. 2025, 15(5), 1689-1714. DOI: 10.7150/thno.103636
Ghazizadeh Y, Sharifi-Ardani SE, Tajik N, Mirzaei R, Pourahmad J. Exploring the Potential of Mitochondria-Targeted Drug Delivery for Enhanced Breast Cancer Therapy. International Journal of Breast Cancer. 2025, 2025, 3013009. DOI: 10.1155/ijbc/3013009
Wang X, Liu J, Durga L, Beeraka NM, Zhou R, Lu P, et al. Recent Updates on the Efficacy of Mitocans in Photo/Radio-therapy for Targeting Metabolism in Chemo/Radio-resistant Cancers: Nanotherapeutics. Current Medicinal Chemistry. 2025, 32(11), 2156-2182. DOI: 10.2174/0109298673259347231019121757
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jinlang Zhang, Junjie Xu, Hu Burong
This work is licensed under a Creative Commons Attribution 4.0 International License.
